Marshaling means that you must try to collect payments from your implant manufacturer before you can receive a payment from the Class 7 Silicone Material Claimants' Fund. Marshaling applies only if you received an implant manufactured by Baxter, Bristol, 3M or McGhan (1984 – 1991). If you have a breast implant from one of these companies but have not received payment, then you must describe the efforts you have taken to obtain a payment.
If your implant manufacturer is Bioplasty, Cox-Uphoff (CUI), or Mentor, then you do not have to attempt to collect any payment or report any payment you received from that manufacturer.
For more information on how to satisfy the Marshaling requirement, go to Section 6.04 (h) (v) of Annex A To The Settlement Facility and Fund Distribution Agreement.